rs375292548
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001171613.2(PREPL):c.1598G>T(p.Arg533Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,606,356 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R533C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001171613.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PREPL | NM_001171613.2 | c.1598G>T | p.Arg533Leu | missense_variant | 11/14 | ENST00000409411.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PREPL | ENST00000409411.6 | c.1598G>T | p.Arg533Leu | missense_variant | 11/14 | 1 | NM_001171613.2 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.000198 AC: 30AN: 151876Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000153 AC: 38AN: 248420Hom.: 1 AF XY: 0.000127 AC XY: 17AN XY: 134302
GnomAD4 exome AF: 0.000117 AC: 170AN: 1454364Hom.: 1 Cov.: 30 AF XY: 0.000102 AC XY: 74AN XY: 723720
GnomAD4 genome ? AF: 0.000197 AC: 30AN: 151992Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74288
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 26, 2023 | The c.1865G>T (p.R622L) alteration is located in exon 11 (coding exon 11) of the PREPL gene. This alteration results from a G to T substitution at nucleotide position 1865, causing the arginine (R) at amino acid position 622 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Myasthenic syndrome, congenital, 22 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Nov 01, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at